Nektar Therapeutics
NKTR
NKTR
239 hedge funds and large institutions have $3.01B invested in Nektar Therapeutics in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 73 increasing their positions, 81 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.07% less ownership
Funds ownership: 6.15% → 6.08% (-0.07%)
10% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 81
Holders
239
Holding in Top 10
1
Calls
$28.1M
Puts
$7.56M
Top Buyers
| 1 | +$8.67M | |
| 2 | +$8.45M | |
| 3 | +$8.09M | |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$7.91M |
| 5 |
Morgan Stanley
New York
|
+$6.23M |
Top Sellers
| 1 | -$29.5M | |
| 2 | -$8.49M | |
| 3 | -$6.21M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$6.1M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$5.52M |